Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Morphology and Kinetics Evolution of Nanoscale Phase in Fe⁻Cr Alloys under External Strain.

Zhu L, Li Y, Shi S, Yan Z, Chen J, Maqbool S.

Nanomaterials (Basel). 2019 Feb 19;9(2). pii: E294. doi: 10.3390/nano9020294.

2.

Nanoscale Phase Evolution during Continuum Decomposition of Fe-Cr Alloys.

Li Y, Zhu L, Liu C, Shi S.

Materials (Basel). 2017 Dec 15;10(12). pii: E1431. doi: 10.3390/ma10121431.

3.

The role of hypertriglyceridemia for acute kidney injury in the course of acute pancreatitis and an animal model.

Wu C, Zou L, Shi S, Tong Z, Shen X, Yang D, Ke L, Li W, Li J.

Pancreatology. 2017 Jul - Aug;17(4):561-566. doi: 10.1016/j.pan.2017.06.006. Epub 2017 Jun 12.

PMID:
28647101
4.

Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma.

Xu Z, Cao C, Xia H, Shi S, Hong L, Wei X, Gu D, Bian J, Liu Z, Huang W, Zhang Y, He S, Lee NP, Chen J.

Front Med. 2016 Mar;10(1):52-60. doi: 10.1007/s11684-016-0433-3. Epub 2016 Jan 25.

PMID:
26809466
5.

[Expression and clinical significance of ZEB2 and E-cadherin in nasopharyngeal carcinoma].

Yi X, Shi S, Li X, Zhao L.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Sep;29(18):1648-51. Chinese.

PMID:
26790269
6.

[Tumor suppressive effect and relative mechanisms of tea polyphenol on nasopharyngeal carcinoma cells].

Tian M, Yuan D, Zheng S, Li Q, Shi S, Xu Z.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Mar;29(6):552-6. Chinese.

PMID:
26211165
7.

[Inhibitive effect of matrine modification X on the growth of human nasopharyngeal carcinoma CNE2 cell xenografts in nude mice].

Shi S, Tang A, Yin S, Wang L, Xie M, Yi X.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Nov;28(21):1697-700. Chinese.

PMID:
25735106
8.

[The inhibited effect of matrine on human nasopharyngeal carcinoma CNE2 cells and the expression of apoptosis related gene Caspase in vitro].

Xie M, He G, Shi S, Liu Y, Chen J, Tang A.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 May;28(9):589-92. Chinese.

PMID:
25195260
9.

Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.

Shi S, Tao L, Song H, Chen L, Huang G.

APMIS. 2014 May;122(5):380-91. doi: 10.1111/apm.12235. Epub 2014 Mar 15.

PMID:
24628659
10.

The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.

Shi S, Qin L, Tian M, Xie M, Li X, Qi C, Yi X.

Tumour Biol. 2014 Jun;35(6):5797-804. doi: 10.1007/s13277-014-1769-4. Epub 2014 Mar 6.

PMID:
24599673
11.

Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models.

Tao L, Huang G, Shi S, Chen L.

Med Oncol. 2014 Jan;31(1):777. doi: 10.1007/s12032-013-0777-3. Epub 2013 Nov 24.

PMID:
24271420
12.

Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.

Shi S, Chen L, Huang G.

Med Oncol. 2013 Dec;30(4):698. doi: 10.1007/s12032-013-0698-1. Epub 2013 Aug 28. Review.

PMID:
23982676
13.

Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.

Shi S, Wang R, Chen Y, Song H, Chen L, Huang G.

PLoS One. 2013 Jun 14;8(6):e65757. doi: 10.1371/journal.pone.0065757. Print 2013.

Supplemental Content

Loading ...
Support Center